Emergent BioSolutions
EBS
#8134
Rank
โ‚น35.01 B
Marketcap
โ‚น682.91
Share price
3.67%
Change (1 day)
-15.17%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): -โ‚น327.18

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -โ‚น332.75. In 2025 the company made an earnings per share (EPS) of โ‚น91.89 an increase over its 2024 EPS that were of -โ‚น351.13.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น327.18-456.05%
2025โ‚น91.89-126.17%
2024-โ‚น351.13-75.61%
2023-โ‚น1,440232.21%
2022-โ‚น433.35-203.46%
2021โ‚น418.84-25.09%
2020โ‚น559.10445.28%
2019โ‚น102.53-15.2%
2018โ‚น120.91-35.9%
2017โ‚น188.6269.57%
2016โ‚น111.24-27.67%
2015โ‚น153.8065.62%
2014โ‚น92.8611.63%
2013โ‚น83.1932.31%
2012โ‚น62.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น73.51-122.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น122.41-136.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น309.31-192.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚น174.11-47.67%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น51.27-115.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น420.78 26.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น60.94-118.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel